首页> 外文期刊>Anesthesia and Analgesia: Journal of the International Anesthesia Research Society >Case report: successful treatment of a patient with trigeminal neuropathy using ziconotide.
【24h】

Case report: successful treatment of a patient with trigeminal neuropathy using ziconotide.

机译:病例报告:使用齐考诺肽成功治疗三叉神经病患者。

获取原文
获取原文并翻译 | 示例
       

摘要

A 50-year-old female patient with chronic neuropathic pain in the distribution of the second branch of the trigeminal nerve was unsuccessfully treated over several years. Intrathecal therapy with ziconotide was administered at an initial dose of 0.33 microg/d, which was gradually increased by 0.7 microg/d. Subjective pain on the numeric rating scale was reduced from 9/10 to 3-4/10 at a dose of 6.3 microg/d. Long-term treatment was continued at a ziconotide concentration of 12.5 microg/mL and a daily dose of 3.9 microg/d by a SynchroMed Infusion System (Medtronic, Minneapolis, MN). Pain reduction was maintained in the follow-up observation period over 5 months.
机译:一名50岁女性,患有三叉神经第二分支分布中的慢性神经性疼痛,但几年来均未成功治疗。用齐考诺肽进行鞘内治疗的初始剂量为0.33微克/天,然后逐渐增加0.7微克/天。数字评分量表上的主观疼痛从6.3 microg / d的剂量从9/10降低到3-4 / 10。通过SynchroMed输液系统(Medtronic,明尼阿波利斯,明尼苏达州)以Ziconotide浓度12.5 microg / mL和每日剂量3.9 microg / d继续长期治疗。在5个月的随访观察期内,疼痛减轻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号